Solid hamartoma of the pancreas is very rare, and only 3 cases have been reported thus far. A patient underwent pancreaticoduodenectomy due to a mass in the head of the pancreas which was suspected to be a borderline malignant tumor, but the histologic diagnosis turned out to be myoepithelial hamartoma (MEH) or adenomyoma. It was characterized by benign duct and glandular structures surrounded by proliferating smooth muscle, and acinus formation was not observed. Immunohistochemical stain for smooth muscle actin (SMA) was positive in spindle cells, and CD34 was negative, differentiating it from the three previously reported cases of solid hamartoma of the pancreas. MEH is an entity that is on the same spectrum as heterotopic pancreas. MEH is rare and has usually been reported in the gastrointestinal tract. To the best of our knowledge, MEH has never been reported in the pancreas. Therefore we report the world's first documented case of MEH of the pancreas. 
INTRODUCTION

Common features of myoepithelial hamartoma (MEH)
are abnormal glandular formations lined by columnar epithelium and surrounded by smooth muscle cells. 1 
MEH
has been referred to by various names such as incompletely differentiated pancreas, adenomyomas, adenomyosis, and foregut choristomas. 2 The existence of various names indicates that the pathogenesis and clinicopathologic features of this disease entity are not well understood. The rarity of MEH is in part responsible for this.
We experienced a case in which a patient underwent pancreaticoduodenectomy due to a mass in the head of the pancreas that was thought to be a borderline malignant tumor, but which turned out to be a benign tumor histologically. The histologic diagnosis was MEH. MEH itself is an extremely rare disease entity that has been reported in sites in the gastrointestinal tract such as the stomach and small intestine. To the best of our knowledge, MEH has never been reported in the parenchyma of the pancreas. Herein, we report the world's first documented case of MEH of the pancreas with a review of the literature. Tumor markers were normal with CEA and CA-19-9 levels of 1.8 ng/ml (reference range: 0-5 ng/ml) and 9.2 U/ml (reference range: 0-37 U/ml). Chromogranin A, insulin, and glucagon levels were 45.21 ng/ml (reference:
24-97 ng/ml), 5.2 μIU/ml (reference: 2-25 μIU/ml), and 28.7 pg/ml (reference: 40-130 pg/ml), respectively.
An operation was planned as the tumor was thought to be possibly malignant or borderline malignant. Ascites, shelf, or seeding were not present, and a 2×1 cm sized firm mass was palpable at the pancreas head. Pylorus preserving pancreaticoduodenectomy was performed. On gross cross section examination of the specimen, the mass was located at the head of the pancreas. It was a well encapsulated, whitish mass with lobulations. Degenerative changes or hemorrhage were not visible (Fig. 2) . The patient recovered uneventfully and was discharged on the 9 th postoperative day in good condition.
Microscopic examination revealed a well-defined pancreatic parenchymal mass with a pushing border. Hematoxylin-eosin staining showed benign duct and glandular structures surrounded by proliferating smooth muscle cells. Acinus formation was not observed (Fig. 3) . Immunohistochemical stain for smooth muscle actin (SMA) was positive in the spindle cells and CD34 was negative (Fig.   4 ). The histopathology diagnosis was myoepithelial hamartoma (adenomyoma). anlage. Thus, the discussion will limit MEHs to gastrointestinal MEH.
The incidence of MEH is unclear and is only known to be rare. The reported sites of occurrence include stomach, duodenum, jejunum, ileum, and rectum. The stomach seems to be the most common site of occurrence, with 38 case reports until 1998 since the first report in 1903. 
